BIO-key International has secured approximately $3.1 million in gross proceeds as it faces “fundraising obligations” to support its push into the Identity and Access Management (IAM) market.
The financing mechanism, a “warrant inducement agreement,” suggests an urgent need for capital. BIO-key struck a deal with an existing institutional investor to exercise 3.09 million outstanding warrants at a reduced price of $1.02 per share. As the “inducement” to get this cash immediately, BIO-key issued the investor 6.18 million new unregistered warrants — double the amount — at the same $1.02 exercise price. This is a highly dilutive trade-off, indicating significant pressure to fund operations and “biometric IAM deals”.
The company appeared to engage in strategic narrative management by issuing this financing news on the exact same day it announced a new, positive growth story. The second announcement detailed a partnership with Scandinavian distributor IT2Trust to carry BIO-key’s IAM solutions and biometric scanners in the Nordic region. By releasing the expansion news alongside the dilutive financing, BIO-key provided a clear justification for why the immediate capital injection was necessary.
Sources: BIO-key International
—
By the ID Tech Editorial Team
